CID 53354790

Gsk-2485852

Structural Information

Molecular Formula
C27H25BF2N2O6S
SMILES
B(C1=C(C=C(C=C1)CN(C2=C(C=C3C(=C2)OC(=C3C(=O)NC)C4=CC=C(C=C4)F)C5CC5)S(=O)(=O)C)F)(O)O
InChI
InChI=1S/C27H25BF2N2O6S/c1-31-27(33)25-20-12-19(16-4-5-16)23(13-24(20)38-26(25)17-6-8-18(29)9-7-17)32(39(2,36)37)14-15-3-10-21(28(34)35)22(30)11-15/h3,6-13,16,34-35H,4-5,14H2,1-2H3,(H,31,33)
InChIKey
GDSKPIAEYNJODX-UHFFFAOYSA-N
Compound name
[4-[[[5-cyclopropyl-2-(4-fluorophenyl)-3-(methylcarbamoyl)-1-benzofuran-6-yl]-methylsulfonylamino]methyl]-2-fluorophenyl]boronic acid
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

5
References

30
Patents

554.1494 Da
Monoisotopic Mass

None
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 555.15668 229.9
[M+Na]+ 577.13862 240.3
[M+NH4]+ 572.18322 233.7
[M+K]+ 593.11256 237.3
[M-H]- 553.14212 240.1
[M+Na-2H]- 575.12407 236.2
[M]+ 554.14885 235.5
[M]- 554.14995 235.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe